4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001193125-25-258574
Chief Financial Officer sold 21,664 shares at $7.29 ($157,931)
From the SEC's structured data for this filing
Trades in this filing
Catinazzo Thomas · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-28 | Sale : show line 1 in the form | −21,664 | $7.29 | $157,931 | 313,631 | D |
| Open-market sales · 21,664 sh · avg $7.29 · $157,931 | ||||||
Loading xslF345X05/ownership.xml…